If you are wondering whether Pfizer's current share price offers value for what you are getting, this article breaks down the ...

Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...

Madrigal Pharmaceuticals obtains global rights to Pfizer's ervogastat. It intends to pair it with Rezdiffra to advance ...

Four recent deals fueled more angst about China’s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to ...

Presenting at the annual J.P. Morgan Healthcare Conference on Monday, Moderna said it expects 2025 revenue of roughly $1.9 ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

The pharmaceutical sector is highly regulated, as it should be, given the direct impact on lives involved with medical care.

Healthcare industry innovator Dr Melanie Ivarsson has been appointed as CEO of the HDRS to accelerate medical breakthroughs. ...

A deal with Revolution could give Merck access to its experimental drug daraxonrasib, which is in late-stage trials and has ...

After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...

The State Street SPDR S&P Biotech ETF, which trades under the ticker XBI, was down 2.1% on Monday morning, a sign of a shift ...